News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Atreca, Inc., Licenses Transformational “Immune Repertoire Capture” Technology From Stanford University


8/14/2012 9:42:18 AM

SAN CARLOS, Calif.--(BUSINESS WIRE)--Atreca, Inc., today announced that Stanford University has granted the company an exclusive license to transformational technology for harnessing the power of the immune response to generate a wide range of medical products.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES